Holen Sie sich die Stockscreener-App
73.15
0.89%
-0.66
Handel nachbörslich:
73.15
Schlusskurs vom Vortag:
$73.81
Offen:
$74.59
24-Stunden-Volumen:
1.66M
Relative Volume:
1.02
Marktkapitalisierung:
$13.09B
Einnahmen:
$342.96M
Nettoeinkommen (Verlust:
$-864.29M
KGV:
-13.88
EPS:
-5.27
Netto-Cashflow:
$-636.03M
1W Leistung:
+10.35%
1M Leistung:
-0.72%
6M Leistung:
+202.77%
1J Leistung:
+208.26%
1-Tages-Spanne:
$72.94
$74.63
1-Wochen-Bereich:
$64.86
$74.63
52-Wochen-Spanne:
$21.92
$80.53
Insmed Inc Stock (INSM) Company Profile
Firmenname
Insmed Inc
Sektor
Branche
Telefon
908-977-9900
Adresse
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Vergleichen Sie INSM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| INSM | 73.15 | 13.09B | 342.96M | -864.29M | -636.03M | -5.27 |
| VRTX | 450.97 | 116.14B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 738.00 | 81.10B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 605.92 | 36.23B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 244.89 | 31.59B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 113.13 | 27.12B | 3.30B | -501.07M | 1.03B | 11.54 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-02-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2023-11-20 | Fortgesetzt | JP Morgan | Overweight |
| 2023-07-26 | Eingeleitet | Guggenheim | Buy |
| 2022-12-09 | Eingeleitet | Mizuho | Buy |
| 2022-12-07 | Eingeleitet | Barclays | Overweight |
| 2022-11-18 | Eingeleitet | BofA Securities | Buy |
| 2022-04-27 | Eingeleitet | Goldman | Buy |
| 2021-12-06 | Eingeleitet | JP Morgan | Overweight |
| 2021-10-19 | Fortgesetzt | Monness Crespi & Hardt | Buy |
| 2021-10-19 | Fortgesetzt | Morgan Stanley | Overweight |
| 2021-10-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-12-17 | Eingeleitet | Berenberg | Buy |
| 2020-10-12 | Fortgesetzt | Stifel | Buy |
| 2019-09-03 | Eingeleitet | Goldman | Buy |
| 2019-04-09 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-15 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-17 | Hochstufung | Goldman | Neutral → Buy |
| 2019-01-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-08-06 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-07-23 | Eingeleitet | Goldman | Neutral |
| 2018-04-23 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-03-21 | Eingeleitet | Morgan Stanley | Overweight |
| 2018-01-18 | Eingeleitet | Credit Suisse | Neutral |
| 2017-09-05 | Bestätigt | Evercore ISI | Outperform |
| 2017-08-17 | Eingeleitet | Evercore ISI | Outperform |
| 2017-07-11 | Eingeleitet | Robert W. Baird | Outperform |
| 2016-03-15 | Eingeleitet | Stifel | Buy |
| 2015-11-09 | Herabstufung | UBS | Buy → Neutral |
| 2015-10-06 | Bestätigt | H.C. Wainwright | Buy |
| 2015-06-09 | Eingeleitet | Citigroup | Neutral |
| 2014-03-26 | Bestätigt | HC Wainwright | Buy |
Alle ansehen
Insmed Inc Aktie (INSM) Neueste Nachrichten
Insmed (NASDAQ:INSM) Price Target Raised to $83.00 at JPMorgan Chase & Co. - MarketBeat
Eagle Asset Management Inc. Sells 51,455 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Demystifying Insmed: Insights From 7 Analyst Reviews - Benzinga
Swiss National Bank Boosts Stake in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Insmed Incorporated (NASDAQ:INSM) Stock Holdings Lifted by Jennison Associates LLC - MarketBeat
Insmed (NASDAQ:INSM) Shares Gap UpWhat's Next? - MarketBeat
Energizer, C3.ai, Insmed And Other Big Stocks Moving Higher On Tuesday - Benzinga
Insmed ends sales agreement with Leerink Partners By Investing.com - Investing.com Canada
Insmed gains after ending $500M sales pact with Leerink - MSN
Insmed stock gains as $500M sales pact ends (INSM:NASDAQ) - Seeking Alpha
Insmed Incorporated (NASDAQ:INSM) is First Turn Management LLC's 3rd Largest Position - MarketBeat
Oppenheimer Asset Management Inc. Grows Stake in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Insmed's Options: A Look at What the Big Money is Thinking - Benzinga
Analysts Set Insmed Incorporated (NASDAQ:INSM) Price Target at $83.07 - MarketBeat
Victory Capital Management Inc. Buys 308,819 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
WCM Investment Management LLC Purchases 54,806 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Notable Monday Option Activity: INSM, MARA, ALGM - Nasdaq
Insmed stock target reduced, keeps Outperform on Q3 report By Investing.com - Investing.com Canada
TimesSquare Capital Management LLC Invests $35.32 Million in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Principal Financial Group Inc. Acquires 214,130 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet - Benzinga
Fiera Capital Corp Sells 13,112 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Van ECK Associates Corp Invests $9.14 Million in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Citizentribune
Insmed Issues $4.6M in Stock Options to New Hires at $68.32 Share Price | INSM Stock News - StockTitan
Insmed To Present at November 2024 Investor Conferences - Marketscreener.com
Insmed (INSM) Set for Major Healthcare Conference Circuit: 4 Key Investor Events in November | INSM Stock News - StockTitan
17,682 Shares in Insmed Incorporated (NASDAQ:INSM) Acquired by Harbor Capital Advisors Inc. - MarketBeat
Insmed's SWOT analysis: rare disease biotech stock poised for growth By Investing.com - Investing.com Canada
Insmed's SWOT analysis: rare disease biotech stock poised for growth - Investing.com
New York State Common Retirement Fund Sells 29,520 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
INSMInsmed, Inc. Latest Stock News & Market Updates - StockTitan
Insmed (INSM) Reliance on International Sales: What Investors Need to Know - Yahoo Finance
Emerald Advisers LLC Buys 49,540 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Insmed's Q3 Loss Wider Than Expected, Sales In Line With Estimates - MSN
Insmed (NASDAQ:INSM) Announces Earnings Results - MarketBeat
Insmed Incorporated (NASDAQ:INSM) Q3 2024 Earnings Call Transcript - Insider Monkey
Insmed (INSM) Reports Q3 Loss, Tops Revenue Estimates - MSN
Insmed (INSM) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates - MSN
Earnings call: Insmed reports strong Q3 growth, eyes brensocatib launch - Investing.com
Earnings call: Insmed reports strong Q3 growth, eyes brensocatib launch By Investing.com - Investing.com UK
Do You Believe in the Growth Potential of Insmed (INSM)? - Yahoo Finance
Truist Financial Reaffirms Buy Rating for Insmed (NASDAQ:INSM) - MarketBeat
Insmed Third Quarter 2024 Earnings: EPS Misses Expectations - Yahoo Finance
Decoding Insmed Inc (INSM): A Strategic SWOT Insight - GuruFocus.com
Insmed Inc (INSM) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Insmed Inc (INSM) Q3 2024 Earnings Call Highlights: Strong Reven - GuruFocus.com
Insmed: Q3 Earnings Snapshot - The Advocate
Insmed (INSM) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance
Insmed Reports Third-Quarter 2024 Financial Results and Provides Business Update - PR Newswire
Finanzdaten der Insmed Inc-Aktie (INSM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Insmed Inc-Aktie (INSM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Smith Michael Alexander | Chief Legal Officer |
Sep 13 '24 |
Sale |
74.35 |
27,871 |
2,072,223 |
67,856 |
| Flammer Martina M.D. | Chief Medical Officer |
Sep 13 '24 |
Option Exercise |
34.03 |
26,969 |
917,755 |
133,103 |
| Flammer Martina M.D. | Chief Medical Officer |
Sep 16 '24 |
Option Exercise |
34.03 |
13,436 |
457,227 |
119,570 |
| Flammer Martina M.D. | Chief Medical Officer |
Sep 12 '24 |
Option Exercise |
34.03 |
635 |
21,609 |
106,769 |
| Flammer Martina M.D. | Chief Medical Officer |
Sep 13 '24 |
Sale |
74.90 |
26,969 |
2,019,978 |
106,134 |
| Flammer Martina M.D. | Chief Medical Officer |
Sep 16 '24 |
Sale |
74.92 |
13,436 |
1,006,625 |
106,134 |
| Flammer Martina M.D. | Chief Medical Officer |
Sep 12 '24 |
Sale |
74.92 |
635 |
47,574 |
106,134 |
1.89%
2.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):